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ABSTRACT Ionotropic glutamate receptors are essential for fast synaptic nerve transmission. Recent x-ray structures for
the ligand-binding (S1S2) region of the GluR2 -amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA)-sensitive
receptor have suggested how differences in protein/ligand interactions may determine whether a ligand will behave as a full
agonist. We have used multiple molecular dynamics simulations of 2–5 ns duration to explore the structural dynamics of
GluR2 S1S2 in the presence and absence of glutamate and in a complex with kainate. Our studies indicate that not only is
the degree of domain closure dependent upon interactions with the ligand, but also that protein/ligand interactions influence
the motion of the S2 domain with respect to S1. Differences in domain mobility between the three states (apo-S1S2,
glutamate-bound, and kainate-bound) are surprisingly clear-cut. We discuss how these changes in dynamics may provide an
explanation relating the mechanism of transmission of the agonist-binding event to channel opening. We also show here how
the glutamate may adopt an alternative mode of binding not seen in the x-ray structure, which involves a key threonine (T480)
side chain flipping into a new conformation. This new conformation results in an altered pattern of hydrogen bonding at the
agonist-binding site.
INTRODUCTION
Fast synaptic transmission between nerve cells in mammals
is carried out predominantly by ionotropic glutamate recep-
tors (iGluR). These receptors are a family of ligand-gated
ion channels that open in response to the binding of gluta-
mate (Dingledine et al., 1999; Sprengel et al., 2001). Glu-
tamate is released presynaptically and binds to a post-
synaptic receptor gating a cation-selective channel, thus
depolarizing the post-synaptic cell. Although glutamate is
the natural ligand, the various iGluRs identified by se-
quence comparisons may also be classified in terms of their
agonist pharmacology (Hollmann and Heinemann, 1994).
Those receptors (GluR1–4) that show greatest sensitivity to
the synthetic agonist -amino-3-hydroxy-5-methyl-4-isox-
azole propionic acid (AMPA) are termed AMPA receptors
(Borges and Dingledine, 1998). Likewise, those that show
greatest sensitivity to kainate (GluR5–7 and KA1–2) are
referred to as kainate receptors (Lerma et al., 1997; Chitta-
jallu et al., 1999). Receptors activated by the synthetic
N-methyl-D-aspartate (NMDAR1 and NMDAR2a–d) are
called NMDA receptors (Yamakura and Shimoji, 1999) and
need glycine and glutamate as the natural agonist. In all of
these GluRs the agonist/antagonist binding site is located
within the extracellular (EC) region of the protein (Fig. 1).
Preceding the glutamate-binding domains is an amino-ter-
minal domain (ATD). This has 16% sequence identity to
the bacterial leucine/isoleucine/valine-binding protein
(O’Hara et al., 1993). Although the ATD is not directly
involved in ligand binding, it has been shown to be impor-
tant for subtype-specific interactions (Leuschner and Hoch,
1999). The polypeptide chain then proceeds to make up
most of domain S1 of the ligand-binding site before forming
two transmembrane (TM) helices (M1 and M2) and an
intervening P-loop, suggestive of an inverted potassium
channel TM architecture (Panchenko et al., 2001). As it
leaves M2 the polypeptide chain then forms most of domain
S2 in the ligand-binding cleft before forming a third TM
helix, M3, followed by a short C-terminus. The x-ray
structure of a water-soluble construct corresponding to
the ligand-binding domains (S1S2) of the EC region of
GluR2 was first solved by Armstrong et al. (1998), re-
vealing the agonist-binding site to lie at the interface
between S1 and S2.
Evidence from single-channel recordings on homomeric
GluR4(i) receptors showed that currents elicited by kainate
as the agonist were up to eightfold smaller than those
elicited by AMPA or glutamate (Smith et al., 2000). Hence,
kainate may be thought of as a partial agonist of the AMPA
receptor. Recently, a series of high-resolution crystal struc-
tures of different agonists and of an antagonist (DNQX)
bound to the GluR2 ligand-binding domain was published
(Armstrong and Gouaux, 2000). Comparison of these struc-
tures of the AMPA- and glutamate-bound complexes re-
vealed a domain closure of20° relative to the apo state. In
contrast, the partial agonist kainate induced a domain clo-
sure of only 12° .
Although it is evident that inter-domain movement occurs
upon ligand binding, x-ray structures provide only static
snapshots of a dynamic process. In this paper we use mo-
lecular dynamics (MD) simulations to explore changes in
the conformational dynamics of the GluR2 ligand-binding
construct in response to different patterns of binding-site
occupancy, i.e., no ligand versus full agonist (glutamate)
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versus partial agonist (kainate). These simulations provide
an insight into agonist dependency of the dynamics of the
ligand-binding construct on a multi-nanosecond timescale.
METHODS
Crystal structures (Armstrong and Gouaux, 2000) for the glutamate (1FTJ),
kainate (1FWO), and the apo (1FTO) states of the S1S2 construct were
downloaded from www.rcsb.org. The 1FTJ coordinate set of the glutamate-
bound state was used to generate an additional apo state (hereafter referred
to as Apo2) from which the glutamate was removed and the binding site
solvated with five additional water molecules (Table 1). We use the same
residue numbering as that employed by Armstrong and Gouaux (2000) for
ease of comparison. Missing residues were added using the molecular
editor in Quanta (Accelrys, San Diego, CA) and the N- and C-termini were
acetylated and amidated, respectively, to mimic the continuation of the
protein chain. Before MD simulations were started, we performed pKA
calculations (Adcock et al., 1998) to determine whether any of the binding-
site residues were likely to adopt nonstandard ionization states. On the
basis of the results of these calculations, all residues were modeled in their
default ionization states.
Crystallographic waters within 4 Å of the protein were retained. Each of
the three starting structures (glutamate-bound, kainate-bound, and apo)
were solvated by a box of 11,000 simple point charge (SPC) (Hermans
et al., 1984) water molecules (Table 1) and the appropriate number of
counterions were added to ensure overall neutrality of the system. The
protein and ligands were then subjected to a restrained run of 200 ps,
whereby the protein (and ligand if present) were harmonically restrained
with a force of 1000 kJ mol1. After this period all restraints were removed
and the simulations run for 2 ns. For simulation of Apo2 this was extended
to 5 ns. Electrostatics were calculated using particle mesh Ewald (PME)
(Darden et al., 1993; Essman et al., 1995) with a 10-Å cutoff. The
temperature was coupled with the Berendsen thermostat (Berendsen et al.,
1984), at 300 K with T  0.1 ps. The time step for integration was 2 fs,
and coordinates and velocities were saved every 5 ps. The LINCS (Hess et
al., 1997) algorithm was used to restrain bond lengths. All simulations were
performed using GROMACS (http://rugmd0.chem.rug.nl/gmx/in-
dex.html) (Berendsen et al., 1995) running on a Silicon Graphics Origin
2000 computer.
RESULTS
Domain closure and inter-domain motions
Comparison of the crystal structures of the S1S2 construct
with and without agonists (Armstrong and Gouaux, 2000)
suggested that the degree of domain closure between the
two domains could be responsible for differences in the
effectiveness of ligands as agonists. In our MD simulations
we wanted to explore this aspect further in terms of the
intra- and inter-domain motion and of how the motion of the
domains is influenced by the ligand.
The drift of each simulated structure from its initial
crystallographic conformation provides information on the
quality of the simulations. The drift was measured in terms
of the root mean square deviation (RMSD) of the C atoms
from the initial structures as a function of time. For the three
(Apo1, Glu1, and Kai) simulations after an initial rise (dur-
ing the first 300 ps) the C RMSD plateaus at 1.25 Å
(data not shown). This is indicative of a stable simulation.
To obtain an initial estimate of the relative motions of the
FIGURE 1 (A) Overall topology of the Glu-R2 protein. ATD represents
the amino-terminal domain (thought to be involved in tetramerization of
the receptor). S1 and S2 are the two domains that make up the region that
binds the ligand (L), i.e., glutamate. M1, P, M2, and M3 make up the
transmembrane region of each subunit. (B) X-ray structure of the S1-S2
construct (Armstrong and Gouaux, 2000). The linker region is indicated by
a black rod. The bilobal domain architecture is marked by the dashed line,
with the S1 domain above and the S2 domain below this line. The
ligand-binding site is shown occupied by glutamate. Figure drawn with
Molscript (Kraulis, 1991) and POV-ray (http://www.povray.org).










Apo1 1FTO 12510 40499 2
Apo2 1FTJ 10446 33941 5
Glu1 1FTJ Glutamate 10336 33938 2
Protomer A
Glu2 1FTJ Glutamate 10974 35539 2
Protomer C*
Kai 1FWO Kainate 11102 36155 2
*In Glu2, protomer C from the x-ray structure was employed, which has
the peptide bond between Asp651 and Ser652 in a flipped conformation,
whereas simulation Glu1 used protomer A, in which (as in all of the other
simulations) the 651-652 bond is not flipped (see main text for further
details).
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two domains during the 2 ns, we determined the C RMSD
of the second domain (S2) after fitting the S1 domain C
atoms to the initial structure(s) (Fig. 2 A). In this case the
domain S2 C RMSDs for the Glu1 and Kai simulations
plateau at 1.5 Å after 300 ps. In contrast, the Apo1
simulation shows a C RMSD, which rises to 3 Å and
exhibits much greater fluctuations than for either of the
liganded states.
This comparison can be extended by fitting the domain
S1 protein coordinates (saved every 20 ps) on top of the
initial structure(s) and examining the backbone traces of the
protein (Fig. 2 B). From this diagram it is evident that there
is a progressive increase in the motion of domain S2 (rela-
tive to domain S1) from Glu1 to Kai to Apo1. This suggests
that the full agonist results in greater immobilization of the
domains relative to one another than does the partial ago-
nist. This is in addition to differences in the degree of
(static) domain closure observed in the x-ray structures
(Armstrong and Gouaux, 2000).
A further measure of the quality of our simulations is
provided by comparison of temperature (B) factors calcu-
lated from simulation root mean square fluctuations
(RMSFs) with those determined experimentally in the x-ray
diffraction studies. We found good agreement of the calcu-
lated B-factors from the simulation with those reported in
the crystallographic structures. A couple of residues located
on the outer surface loops had values higher than those
reported, but generally the simulated values were consis-
tently lower than the experimental values by 5 Å2. Given
we observed a significant difference in inter-domain motion
induced by different ligands, we wished to reassure our-
selves that the mean conformation of the protein in our
simulations retained the domain closure seen in the crystal
structures. Therefore, we determined inter-domain distance
matrices averaged over the whole duration of each simula-
tion (Fig. 3). These quite clearly reveal the gradient in
inter-domain contacts between the Apo1 simulation (fewest
contacts) and the Glu1 simulation (most contacts). The
mean distances of these contacts are in accord with the
mean degree of domain closure observed in the crystal
structures, indicating that the average behavior in the MD
simulations reproduces the crystallographic averages. As an
additional check we compared the radius of gyration (of the
C atoms) for each of the simulations to provide a measure
of the overall compactness of the protein. A clear distinction
can be seen between the mean radius of gyration (RGYR) for
the three different simulations with Apo1 (RGYR  19.2
Å)  Kai (RGYR  18.7 Å)  Glu1 (RGYR  18.4 Å).
Furthermore, the fluctuations in the radius of gyration are
much greater for Apo1, again indicative of significant inter-
domain motion. Thus, this analysis supports the conclusion
reached by visualization of the inter-domain motions.
Apo2 simulation
We have also performed a simulation (Apo2) starting from
the conformation of the protein observed in the crystal
structure with glutamate bound, but with the ligand re-
moved and replaced by water molecules (see above). Thus
the protein is in the domains-closed state, but without any
stabilizing ligand. This simulation was run for 5 ns. Even on
this timescale we did not see any evidence of net movement
of the domains relative to one another to yield a conforma-
tion resembling that in Apo1. We suspect that much longer
simulations (100 ns) might be required to see such a
conformational change, although domain motions have on
occasions been seen in 2-ns simulations (Roccatano et al.,
2001).
We have applied the various analyses described above to
the Apo2 simulation. The drift from the initial structure seen
in the RMSD plots is similar to that observed for the Glu1
simulation, implying that the protein maintains a conforma-
tion that is similar to the glutamate-bound state. The radius
of gyration for the Apo2 simulation is 18.4 Å across the
whole 5 ns, which is identical to the value observed for the
Glu1 simulation.
FIGURE 2 (A) C RMSD of the S2 domain relative to the S1 domain as
a function of time for the Apo1 (——), Kai (  ), and Glu1 (- - - -)
simulations. The increased fluctuation of the Apo1 state is evident. (B)
Superimposed backbone traces (saved every 200 ps) of the C atoms for
these three simulations. The difference in the movement of the S2 domain
relative to the S1 domain between the simulations is clearly discernible.
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Multiple peptide bond conformations
In their analysis of the crystal forms, Armstrong et al.
(1998) observed a flip in the peptide bond between Asp651
and Ser652 for the AMPA-bound and in one of three glu-
tamate-bound protomers. They suggested that the switch of
this residue from an unflipped to a flipped conformation
was related to receptor activation. Our initial simulation
(Glu1) was based upon protomer A, which in the crystal was
observed in an unflipped conformation. During the 2-ns
Glu1 simulation we did not observe any change in the
backbone torsion ( and ) angles in this region. We
investigated this aspect further by running a simulation
(Glu2; see Table 1) starting from protomer C, which has the
flipped conformation of the peptide bond. Within 600 ps,
we observed the  angle of Ser652 to rotate through
50–60 ° (Fig. 4) and remain in that new conformation for
the remainder of the simulation. The new conformation is
closer to the protomer B conformation in the crystal. Thus,
our simulations suggest that in the presence of glutamate,
multiple conformations of the Ser652 can exist, as in the
x-ray structure. Although it has been postulated that this
flipping could be related to receptor activation it is very
difficult to make any conclusion with respect to the mech-
anism for two reasons. The first is the timescale of this
simulation with respect to the timescale of activation; such
a mechanism of activation must involve conformation
changes in the region of the linker, for to observe such a
propagation of conformational change would require
multiple long simulations. Second, it could be that the
presence of the linker in this region alone infers different
conformation changes than that which occur in the full-
length receptor.
The overall RGYR for the Glu2 simulation was 18.4 Å,
i.e., identical to that observed for the Glu1 simulation. Our
analysis of the RMSD plots also indicated that the overall
behavior of the protein in Glu2 was similar to that in the
Glu1 simulation.
Binding modes
What is the main distinction between glutamate (a full
agonist) and kainate (a partial agonist)? The answer must lie
within their manners of binding. We thus examined in detail
interactions at the binding sites in the Glu1 and Kai simu-
lations. The binding site is comprised of an intricate net-
work of hydrogen bonds (Fig. 5). It can be seen that the key
interactions of domain S1 involving Arg485, Thr480, and
Pro478 are seen with both ligands as are the key interactions
of domain S2 involving Ser654, Thr655, and Glu705. We
have monitored the existence and duration of these key
H-bond interactions throughout the Glu1 and Kai simula-
tions (Glu1 and Kai; Fig. 6). Distinct differences are ob-
served between the two ligands in terms of the hydrogen-
bond lifetimes.
FIGURE 3 (A) Mean inter-domain distance matrices for the Apo1, Kai, and Glu1 simulations. Each matrix represents the C-C distances averaged
across the corresponding simulation. Interactions nearer than 4 Å are indicated by a white square. The increased number of inter-domain contacts in the
Glu1 simulation is apparent. The major regions of contact in the Glu1 simulation are ringed.
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For both ligands, Arg485 is observed to maintain the
largest number of contacts for long lifetimes in agreement
with the observation (Armstrong and Gouaux, 2000) that
this residue is the primary anchor for the -carboxyl group
of the ligand and with experiments indicating that mutations
of this residue invariably lead to loss of function (Uchino et
al., 1992; Wafford et al., 1995; Kawamoto et al., 1997).
However, there are also some clear differences between the
two ligands. In simulation, Glu1 H-bond analysis revealed
two additional long-lived interactions, not present in the
starting structure. These appeared after 1 ns and were be-
tween 1) the NH of Glu and the Thr480 backbone OG atom
and 2) the glutamate O and the Arg485 side-chain NH. This
was examined closer and was found to be due to flipping
(by 100°) around the C-C bond of the side chain of
Thr480 (Fig. 7). The lengths and angles of these H-bonds
are summarized in Table 2. Qualitatively, a change is seen
whereby a protein/protein H-bond (Thr480-Arg485) is re-
placed by two H-bonds from these side chains to the ligand,
glutamate. It should be noted that a similar flipping of
Thr480 was not seen during the kainate simulation, possibly
due to the presence of the ring in the ligand allowing less
flexibility in the binding site.
FIGURE 4 Backbone torsion angles as a function of time for simulation
Glu2 (starting with monomer C from the crystal structure). (A)  of Ser652;
(B)  of Gly653. In the crystal structure there are three monomers (see text)
with corresponding torsion angles: Ser652A,   118°; Gly653A,  
167°; Ser652B,   53°; Gly653B,   138°; Ser653C,   27°;
and Gly653C,   125° .
FIGURE 5 Key interactions of the binding sites for the glutamate and
kainate binding sites, respectively. The structures are the minimized ones
before the start of the restrained run. The diagram was generated with the
program LIGPLOT (Wallace et al., 1995).
FIGURE 6 Hydrogen bonds versus time for key ligand/protein interac-
tions for the Glu1 (A) and Kai (B) simulations. (Atom numbers are defined
in Fig. 5.)
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We have analyzed the energetics of these binding modes.
The enthalpic energy difference between the two different
binding modes for glutamate is not significant. An accurate
value for the enthalpic binding energy between glutamate
and kainate is not possible from these simulations, but an
approximate calculation reveals that the difference is sub-
stantial (of the order of 100 kcal/mol).
DISCUSSION
The main achievements of these simulations have been 1)
to reveal a correlation between intra-domain mobility and
receptor occupation, such that low mobility corresponds
to occupancy by a full agonist, and 2) to show that
binding of glutamate to the S1S2 protein may be
strengthened beyond that present in the crystal by rota-
tion of the Thr480 side chain. Thus, the simulations may
reveal aspects of GluR activation additional to those
observed in the x-ray structures.
The principal limitations of the simulations are their
relatively short duration, a result of computational limita-
tions for atomistic simulations of relatively large systems
(40,000 atoms). This short duration is problematic with
respect to two distinct areas. The first of these is that the
activation event (from ligand binding to channel opening) is
of the order of milliseconds, and it is thus unwise to extrap-
olate beyond these current results. The second consideration
is that of statistical sampling. We have performed reason-
ably long simulations, but only one flipping event around
the Thr480 C-C bond is observed for example. Ideally
one should run these simulations many more times to ensure
greater confidence that the observed events are a significant
property of the system. One would also like to be able to
estimate how well conformation space has been sampled.
We are quite certain that many more simulations would be
needed to start to address this issue more fully.
Furthermore, even after extending the Apo2 simulation to
5 ns it was not possible to observe a conformational tran-
sition corresponding to domain opening in the absence of
ligand. Comparisons of the different crystal structures pro-
vide clear evidence of domain opening/closure (Armstrong
and Gouaux, 2000). However, applying similar analyses
(Hingefind (Wriggers and Schulten, 1997) and DynDom
(Hayward and Berendsen, 1998)) to any single simulation
failed to reveal any movement of the domains that could be
dissected into bilobal hinge motions. This also suggests that
domain closure is on a much longer timescale than is
accessible in current simulations. Indeed, a similar obser-
FIGURE 7 Diagram of flipping of the side chain of Thr480 in the Glu1
simulation. At 0.5 ns the 1 (C-C-C-OG) torsion is 67 °. At 1.5 ns
it flips to a value of 165 °. Figure was drawn with VMD (Humphrey et
al., 1996).
TABLE 2 Hydrogen bonding in the binding site for the Glu1 simulation
Hydrogen bonds
State 1 (0–500 ps) State 2 (1500–2000 ps)
Distance (Å) Angle, C™O™H Distance (Å) Angle, C™O™H
Thr480:NHOXT:Glu 1.8 142° 2.1 121°
Arg485:NH1O:Glu 2.6 120° 2.3 87°
Arg485:NH2O:Glu 2.2 114° 2.3 114°
Arg485:NH1OXT:Glu 2.2 90°
Pro478:OH3N:Glu 2.4 165° 2.9 128°
Pro478:OH2N:Glu 2.9 132° 2.7 159°
Thr485:OGH1N:Arg485 1.9 150°
Thr485:OGH3N:Glu 2.2 153°
The table summarizes key H-bonds between ligand (Glu) and protein in the Glu1 simulation. State 1 refers to the first part of the simulation (before the
Thr480 side-chain flip), and state 2 refers to the latter part of the simulation. Distances and angles are given SD. Distances are to the hydrogens of
H-bonds.
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vation was made for nanosecond simulations of an SH2-
SH3 domain system (Young et al., 2001), where domain
movement was known to exist. Furthermore, it seems that
rare events on this timescale may not be directly observable,
but the collective motions that contribute to their behavior
may well be (Tai et al., 2001).
The other major limitation, shared with the x-ray stud-
ies, is that our studies are of the water-soluble S1S2
construct rather than the intact GluR2 protein. However,
as shown and discussed in Armstrong and Gouaux
(2000), the binding curves for 3H-AMPA and the IC50
values for ligand displacements are very similar to longer
S1S2 constructs (Chen and Gouaux, 1997) and to those
for the full-length receptor (Keina¨nen et al., 1990). Thus
it seems likely that the pharmacological properties of the
S1S2 construct parallel those of the GluR2 receptor per
se. Intriguingly, although very speculative, we also ana-
lyzed the movement of the linker residues and surround-
ing regions. Although the RMSFs of the linker residues
were very similar in all three simulations, the RMSF
values of the surrounding residues 20 residues either
side of this linker region showed noticeably higher values
for the apo simulation compared with the ligand-bound
simulations. Remaining residues had indistinguishable
RMSF values. In the full-length protein the linker region
would connect to the transmembrane domain, and it is
thus tempting to try to speculate how this may be related
to channel gating, but this will require much longer
simulation times to be able to investigate this with any
confidence.
CONCLUSIONS
Our main conclusion is that it is important to consider the
conformational dynamics of a receptor and to determine
how ligand binding may modulate the dynamics. In partic-
ular, for the GluR2 it seems that agonist binding not only
results in domain closure (as revealed crystallographically)
but also results in a decrease in domain mobility (as re-
vealed in simulations) and that the reduction in mobility is
greater for a full than for a partial agonist. At a more
microscopic level our simulations reveal an important side-
chain flipping motion of a residue (Thr480) in the binding
site that changes the mode of binding of the agonist (glu-
tamate). This side-chain flip generates an alternative mode
of binding not observed for kainate and not observed for
glutamate in the crystal structures. Such an observation may
have important consequences in the consideration of drug
design. However, the timescale of the inter-domain motion
is significantly longer than that which is obtainable by
conventional MD. We are currently extending this work by
using techniques more suited to longer timescales.
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